Collaboration between Myriad Genetics and GSK Expands HRD Testing Reach
Tuesday, 11 June 2024, 11:56
Collaboration for Enhanced Healthcare
In an effort to improve access to HRD testing, Myriad Genetics and GSK have collaborated in nine countries.
Advancing Precision Medicine
This strategic partnership is aimed at enhancing healthcare outcomes globally.
- Significant Step Towards Precision Medicine
The collaboration signifies a key advancement in making genetic testing services more widely accessible.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.